Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 4 , Pages 382-390, July 2009

XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy

  • Marcos B. Pinho, MSc.

      Affiliations

    • Division of Clinical and Translational Research, Research Coordination (CPQ), Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
    • ,
  • Fernanda Costas, B.S.

      Affiliations

    • Division of Clinical and Translational Research, Research Coordination (CPQ), Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
    • ,
  • João Sellos, B.S.

      Affiliations

    • Division of Clinical and Translational Research, Research Coordination (CPQ), Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
    • ,
  • Rodrigo Dienstmann, M.D.

      Affiliations

    • Division of Clinical and Translational Research, Research Coordination (CPQ), Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
    • ,
  • Patricia B. Andrade, M.D.

      Affiliations

    • Eli Lilly do Brasil Ltda., São Paulo, Brazil
    • ,
  • Daniel Herchenhorn, M.D.

      Affiliations

    • Clinical Oncology Service, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
    • ,
  • Fábio Afonso Peixoto, M.D.

      Affiliations

    • Clinical Oncology Service, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
    • ,
  • Valdelice O. Santos, R.N.

      Affiliations

    • Division of Clinical and Translational Research, Research Coordination (CPQ), Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
    • ,
  • Isabele A. Small, MSc.

      Affiliations

    • Division of Clinical and Translational Research, Research Coordination (CPQ), Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
    • ,
  • Denise P. Guimarães, M.D., Ph.D.

      Affiliations

    • Division of Clinical and Translational Research, Research Coordination (CPQ), Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
    • ,
  • Carlos G. Ferreira, M.D., Ph.D.

      Affiliations

    • Division of Clinical and Translational Research, Research Coordination (CPQ), Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55-21-32331421; fax: +55-21-32331411

Received 15 January 2008; received in revised form 4 March 2008; accepted 9 March 2008. published online 16 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(08)00065-3

doi:10.1016/j.urolonc.2008.03.016

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 4 , Pages 382-390, July 2009

Article Tools

* Image Usage & Resolution